Human Genomics and Personalized Medicine (E3)

This meeting program reflects a diverse set of speakers presenting a balanced and complementary view of the field of Human Genomics and Personalized Medicine. Plenary session topics are: 1. Breakthroughs in Genomic and Personalized Medicine; 2. Genomes and Biology; 3. Policy; 4. Advances and Challenges in the Field; 5. Pharmacogenomics; 6. Personalized Genomes; 7. Cancer Genomics and Applications; and 8. Translating Biomarkers to Personalized Medicine.
+ show speakers and program
John Bell, University of Oxford, UK
Breakthroughs in Genomic and Personalized Medicine

Peter Mueller, Vertex Pharmaceuticals Incorporated, USA
Target Therapy for Cystic Fibrosis: From Gene to Patient

Geoffrey S. Ginsburg, Duke University, USA
Novel Host-Based Approaches to the Diagnosis of Infectious Disease

Genomes and Biology

Deborah A. Nickerson†, University of Washington, USA
Talk Title to be Determined

Kelly A. Frazer, University of California, San Diego, USA
The Role of Regulatory Variants in Disease

Andrew P. Feinberg, Johns Hopkins University School of Medicine, USA
The Epigenetic Basis of Common Human Disease

Cancer Genomics and Applications


Paul S. Mischel, University of California, Los Angeles, USA
The Cancer Genome Atlas and the Future of Cancer Diagnosis and Treatment

Steven Shak, Genomic Health Inc., USA
Translating Genomics into Clinical Practice: Lessons from Oncotype DX

Thomas J. Hudson, Ontario Institute for Cancer Research, Canada
Linking Cancer Treatment Decisions with Large-scale Mutation Surveys

Hiroyuki Mano, University of Tokyo/Jichi Medical University, Japan
Targeted Therapies in Cancer


Advances and Challenges in the Field

Janet Woodcock, US Food and Drug Administration, USA
A Regulatory Pathway to Personalized Medicine

Jill Mesirov, Broad Institute, USA
The Complexity of Complex Data

Dan M. Roden, Vanderbilt University School of Medicine, USA
Integration and Implementation of Genetic Information into Health Systems

Howard J. Jacob, Medical College of Wisconsin, USA
Advances in Clinical Sequencing


Pharmacogenomics

Alan R. Shuldiner, University of Maryland School of Medicine, USA
Genomic Management of Anti-Platelet Therapeutics

Howard McLeod, University of North Carolina at Chapel Hill, USA
Pharmacogenetics of Cancer Therapeutics

Keith J. Johnson, Novartis Institutes for BioMedical Research, Inc., USA
Innovations in Pharmacogenomics-Enabled Drug Development

Y.T. Chen, Duke University, USA
Realizing the Promise of Personalized Medicine: HLA-B*1502 Screen in Preventing Carbamazepine-Induced Toxic Effects

Michael Snyder, Stanford University School of Medicine, USA
Adventures in Personal Genomics: iPOP of Healthy and Disease States

William A. Gahl, NHGRI, National Institutes of Health, USA
Whole Exome Sequencing for Undiagnosed Diseases

George M. Church, Harvard Medical School, USA
The Personal Genome Project and the Future of Medicine

Policy

Susanne B. Haga, Duke University, USA
Introducing Genomics in the Clinic: Development of New Delivery Systems

Laura Lyman Rodriguez, NHGRI, National Institutes of Health, USA
Bringing Genomics into Medicine: Advancing the Policy Agenda

Katherine Payne, University of Manchester, UK
Quantifying the Economic Value of Personalized Medicine

Jane Kaye, University of Oxford, UK
Privacy, Data-Sharing Frameworks, Global Governance and Translational Research


Translating Biomarkers to Personalized Medicine

Michelle Penny, Eli Lilly and Company, USA
Integration of Genomic Technologies into Drug Discovery and Development

Jonathan K.C. Knowles, École Polytechnique Fédérale de Lausanne (EPFL), Switzerland
Developing Diagnostics from Biomarkers

Thomas Metcalfe, Oncotest GmbH - Institute for Experimental Oncology, Germany
Co-Development of Therapeutics and Companion Diagnostics


17 Jun - 21 Jun 2013
Stockholm
Sweden
meeting website